Advertisement
Advertisement

DYN

DYN logo

Dyne Therapeutics, Inc. Common Stock

20.70
USD
Sponsored
+0.44
+2.17%
Jun 24, 13:54 UTC -4
Open

DYN Earnings Reports

Positive Surprise Ratio

DYN beat 9 of 23 last estimates.

39%

Next Report

Date of Next Report
Jul 27, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$0.75
Implied change from Q1 26 (Revenue/ EPS)
--
/
+2.74%
Implied change from Q2 25 (Revenue/ EPS)
--
/
-22.68%

Dyne Therapeutics, Inc. Common Stock earnings per share and revenue

On May 11, 2026, DYN reported earnings of -0.73 USD per share (EPS) for Q1 26, beating the estimate of -0.78 USD, resulting in a 6.51% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +4.83% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 9 analysts forecast an EPS of -0.75 USD, with revenue projected to reach -- USD, implying an increase of 2.74% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
For Q1 2026, Dyne Therapeutics, Inc. Common Stock reported EPS of -$0.73, beating estimates by 6.51%, and revenue of $0.00, 0% as expectations.
The stock price moved up 4.83%, changed from $17.61 before the earnings release to $18.46 the day after.
The next earning report is scheduled for Jul 27, 2026.
Based on 9 analysts, Dyne Therapeutics, Inc. Common Stock is expected to report EPS of -$0.75 and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement